Generated automatically from the NAFDAC register, WHO alerts and community data as of today. Not medical advice — always follow your doctor or pharmacist.
From the official U.S. FDA label for poliomyelitis vaccine (opv) (live attenuated), the active ingredient registered with NAFDAC.
INDICATIONS: For temporary relief of fever with digestive symptoms, muscular aches & pains associated with the flu.
For temporary relief of fever with digestive symptoms, muscular aches & pains associated with the flu.
If pregnant or breast-feeding, ask a health care professional before use. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away. Do not use if tamper evident seal is broken or missing. Store in cool, dry place.
Add the expiry date printed on your pack for a full Trust Score — or look up uses, side effects and cheaper generics.
Poliomyelitis Vaccine (Oral) Bivalent Type 1 and 3 contains Poliomyelitis vaccine (OPV) (live attenuated) (0.1 mL), as solution/drops, according to its NAFDAC registration record.
Yes. Poliomyelitis Vaccine (Oral) Bivalent Type 1 and 3 is listed on the NAFDAC register under registration number A6-0253, and its registration is active as of 6 November 2026.
No WHO falsified or substandard medical product alert currently matches Poliomyelitis Vaccine (Oral) Bivalent Type 1 and 3 in our automatically synced alert list.
Run a free authenticity scan with the NAFDAC number A6-0253, your pack's expiry date and batch number to get a Trust Score, compare the pack with the NAFDAC record (ingredient, strength, form, manufacturer), and buy only from licensed pharmacies.
INDICATIONS: For temporary relief of fever with digestive symptoms, muscular aches & pains associated with the flu. (Summarised from the official U.S. FDA label for poliomyelitis vaccine (opv) (live attenuated). Always follow your doctor or pharmacist.)
Reviews are personal experiences from RxVerify users, not medical advice. Report side effects to your doctor and to NAFDAC.